Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Conditions
Interventions
Brodalumab
Placebo
Locations
50
United States
Research Site
Birmingham, Alabama, United States
Research Site
Dothan, Alabama, United States
Research Site
Lowell, Arkansas, United States
Research Site
Jacksonville, Florida, United States
Research Site
Miami, Florida, United States
Research Site
Hammond, Louisiana, United States
Start Date
November 9, 2010
Primary Completion Date
October 15, 2011
Completion Date
October 15, 2011
Last Updated
January 3, 2022
NCT06226883
NCT07184931
NCT06918808
NCT06647615
NCT07377188
NCT07385131
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions